{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T07:54:40Z","timestamp":1793346880507,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T00:00:00Z","timestamp":1596412800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T00:00:00Z","timestamp":1596412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2017YFC1001700"],"award-info":[{"award-number":["2017YFC1001700"]}]},{"name":"National Key Research and Development Program of China","award":["2019YFC1005100"],"award-info":[{"award-number":["2019YFC1005100"]}]},{"name":"National Key Research and Development Program of China","award":["2016YFC0905102"],"award-info":[{"award-number":["2016YFC0905102"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81471097"],"award-info":[{"award-number":["No. 81471097"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission","doi-asserted-by":"crossref","award":["Z141107004414036"],"award-info":[{"award-number":["Z141107004414036"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission","doi-asserted-by":"crossref","award":["Z151100003915126"],"award-info":[{"award-number":["Z151100003915126"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Cobalamin C deficiency (<jats:italic>cblC<\/jats:italic>) caused by the<jats:italic>MMACHC<\/jats:italic>mutations is the most common type of the disorders of intracellular cobalamin metabolism. While the c.609G\u2009&gt;\u2009A mutation is most frequent in Chinese<jats:italic>cblC<\/jats:italic>patients, its correlation with phenotype has not been delineated. Here we aim to investigate the factors affecting variable phenotypes and outcomes associated with the<jats:italic>MMACHC<\/jats:italic>c.609G\u2009&gt;\u2009A homologous mutation in 149 Chinese cases to have implications for treatment and prevention.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We assessed 149<jats:italic>cblC<\/jats:italic>patients caused by<jats:italic>MMACHC<\/jats:italic>c.609G\u2009&gt;\u2009A homozygous mutation. The clinical manifestations, complications, treatment, and outcomes were evaluated; 120 patients were followed-up till December 2019.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Two patients (1.3%) were prenatally diagnosed, treated after birth and consequently showed normal development. In 15 patients (10.1%) detected by newborn screening, 10 were treated at the age of 2\u2009weeks and showed normal development, while the other 5 were treated after onset and showed neurologic disorders. All 132 clinically diagnosed patients (88.6%) developed symptoms at age from few minutes after birth to 72\u2009months. Among them, 101 (76.5%) had early-onset (before the age of 12\u2009months) and 31 (23.5%) had late-onset (after the age of 12\u2009months). Totally 5 patients died and 24 were lost to follow-up. Of the 132 clinical diagnosed patients, 92 (69.7%) presented with developmental delay, 65 (49.2%) had seizures, 37 (28.0%) had anemia, 24 (18.2%) had feeding difficulty, 23 (17.4%) had ocular problems, and 22 (16.7%) had hydrocephalus. Compared with the non-developmental delay group, the onset age, the age at treatment initiation and the time from onset to treatment initiation were later in the developmental delay group. Seizure group showed significantly higher urinary methylmalonic acid concentration. During long-term follow-up, plasma total homocysteine (tHcy) levels were significantly higher in patients in the uncontrolled group than those in the seizure-free group.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Most<jats:italic>cblC<\/jats:italic>patients caused by<jats:italic>MMACHC<\/jats:italic>c.609G\u2009&gt;\u2009A homozygous mutation showed early-onset. The clinically diagnosed patients usually showed the presence of irreversible brain disorders. Patients treated from the pre-symptomatic stage showed favorable outcomes. Therefore, newborn screening, prenatal diagnosis and early treatment are crucial and the c.609G\u2009&gt;\u2009A mutant allele should be listed in the pre-pregnancy carrier screening panel in China.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13023-020-01485-7","type":"journal-article","created":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T12:06:34Z","timestamp":1596456394000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Variable phenotypes and outcomes associated with the MMACHC c.609G&gt;A homologous mutation: long term follow-up in a large cohort of cases"],"prefix":"10.1186","volume":"15","author":[{"given":"Ruxuan","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruo","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinqing","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhehui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxin","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yupeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqiu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiong","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongxiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desheng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,3]]},"reference":[{"key":"1485_CR1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ymgmr.2018.05.003","volume":"16","author":"N Shibata","year":"2018","unstructured":"Shibata N, Hasegawa Y, Yamada K, Kobayashi H, Purevsuren J, Yang Y, et al. Diversity in the incidence and spectrum of organic acidemias, fatty acid oxidation disorders, and amino acid disorders in Asian countries: selective screening vs. expanded newborn screening. Mol Genet Metab Rep. 2018;16:5\u201310.","journal-title":"Mol Genet Metab Rep"},{"issue":"6","key":"1485_CR2","first-page":"414","volume":"56","author":"Y Liu","year":"2018","unstructured":"Liu Y, Liu YP, Zhang Y, Song JQ, Yang YL. Heterogeneous phenotypes, genotypes, treatment and prevention of 1 003 patients with methylmalonic acidemia in the mainland of China. Zhonghua Er Ke Za Zhi. 2018;56(6):414\u201320.","journal-title":"Zhonghua Er Ke Za Zhi"},{"issue":"9","key":"1485_CR3","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/jhg.2010.81","volume":"55","author":"M-Y Liu","year":"2010","unstructured":"Liu M-Y, Yang Y-L, Chang Y-C, Chiang S-H, Lin S-P, Han L-S, et al. Mutation spectrum of MMACHC in Chinese patients with combined methylmalonic aciduria and homocystinuria. J Hum Genet. 2010;55(9):621\u20136.","journal-title":"J Hum Genet"},{"issue":"1","key":"1485_CR4","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s13023-019-1268-1","volume":"14","author":"Y-Z Jiang","year":"2019","unstructured":"Jiang Y-Z, Shi Y, Shi Y, Gan L-X, Kong Y-Y, Zhu Z-J, et al. Methylmalonic and propionic acidemia among hospitalized pediatric patients: a nationwide report. Orphanet J Rare Dis. 2019;14(1):292.","journal-title":"Orphanet J Rare Dis."},{"issue":"3","key":"1485_CR5","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ajhg.2013.07.022","volume":"93","author":"H-C Yu","year":"2013","unstructured":"Yu H-C, Sloan JL, Scharer G, Brebner A, Quintana AM, Achilly NP, et al. An X-linked cobalamin disorder caused by mutations in transcriptional coregulator HCFC1. Am J Hum Genet. 2013;93(3):506\u201314.","journal-title":"Am J Hum Genet"},{"issue":"6","key":"1485_CR6","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.jpeds.2009.06.046","volume":"155","author":"HJ Lin","year":"2009","unstructured":"Lin HJ, Neidich JA, Salazar D, Thomas-Johnson E, Ferreira BF, Kwong AM, et al. Asymptomatic maternal combined Homocystinuria and Methylmalonic Aciduria (cblC) detected through low Carnitine levels on newborn screening. J Pediatr. 2009;155(6):924\u20137.","journal-title":"J Pediatr"},{"issue":"7","key":"1485_CR7","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/humu.21001","volume":"30","author":"JP Lerner-Ellis","year":"2009","unstructured":"Lerner-Ellis JP, Anastasio N, Liu J, Coelho D, Suormala T, Stucki M, et al. Spectrum of mutations in MMACHC, allelic expression, and evidence for genotype\u2013phenotype correlations. Hum Mutat. 2009;30(7):1072\u201381.","journal-title":"Hum Mutat"},{"issue":"2","key":"1485_CR8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1684\/j.1950-6945.2005.tb00106.x","volume":"7","author":"NI Wolf","year":"2005","unstructured":"Wolf NI, Bast T, Surtees R. Epilepsy in inborn errors of metabolism. Epileptic Disord. 2005;7(2):67\u201381.","journal-title":"Epileptic Disord"},{"issue":"11","key":"1485_CR9","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1373\/clinchem.2003.022178","volume":"49","author":"DH Chace","year":"2003","unstructured":"Chace DH, Kalas TA, Naylor EW. Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns. Clin Chem. 2003;49(11):1797\u2013817.","journal-title":"Clin Chem"},{"key":"1485_CR10","doi-asserted-by":"crossref","first-page":"S395","DOI":"10.1007\/s10545-008-0965-z","volume":"31","author":"G la Marca","year":"2008","unstructured":"la Marca G, Malvagia S, Casetta B, Pasquini E, Donati MA, Zammarchi E. Progress in expanded newborn screening for metabolic conditions by LC-MS\/MS in Tuscany: update on methods to reduce false tests. J Inherit Metab Dis. 2008;31:S395\u2013404.","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"1485_CR11","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1620\/tjem.188.317","volume":"188","author":"M Kimura","year":"1999","unstructured":"Kimura M, Yamamoto T, Yamaguchi S. Automated metabolic profiling and interpretation of GC\/MS data for organic acidemia screening: a personal computer-based system. Tohoku J Exp Med. 1999;188(4):317\u201334.","journal-title":"Tohoku J Exp Med"},{"issue":"1","key":"1485_CR12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0378-3782(00)00053-0","volume":"58","author":"F X-w","year":"2000","unstructured":"X-w F, Iga M, Kimura M, Yamaguchi S. Simplified screening for organic acidemia using GC\/MS and dried urine filter paper: a study on neonatal mass screening. Early Hum Dev. 2000;58(1):41\u201355.","journal-title":"Early Hum Dev"},{"issue":"1","key":"1485_CR13","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13023-014-0130-8","volume":"9","author":"MR Baumgartner","year":"2014","unstructured":"Baumgartner MR, H\u00f6rster F, Dionisi-Vici C, Haliloglu G, Karall D, Chapman KA, et al. Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia. Orphanet J Rare Dis. 2014;9(1):130.","journal-title":"Orphanet J Rare Dis."},{"issue":"4","key":"1485_CR14","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1203\/00006450-199604000-00020","volume":"39","author":"Y Shigematsu","year":"1996","unstructured":"Shigematsu Y, Hata I, Nakai A, Kikawa Y, Sudo M, Tanaka Y, et al. Prenatal diagnosis of organic acidemias based on amniotic fluid levels of acylcarnitines. Pediatr Res. 1996;39(4):680\u20134.","journal-title":"Pediatr Res"},{"issue":"1","key":"1485_CR15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jchromb.2005.04.020","volume":"823","author":"Y Hasegawa","year":"2005","unstructured":"Hasegawa Y, Iga M, Kimura M, Shigematsu Y, Yamaguchi S. Prenatal diagnosis for organic acid disorders using two mass spectrometric methods, gas chromatography mass spectrometry and tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2005;823(1):13\u20137.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"1485_CR16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fgene.2018.00007","volume":"9","author":"KJ Guo","year":"2018","unstructured":"Guo KJ, Zhou X, Chen XG, Wu YL, Liu CX, Kong QS. Expanded newborn screening for inborn errors of metabolism and genetic characteristics in a Chinese population. Front Genet. 2018;9:7.","journal-title":"Front Genet"},{"issue":"5","key":"1485_CR17","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.braindev.2015.10.016","volume":"38","author":"B Han","year":"2016","unstructured":"Han B, Cao Z, Tian L, Zou H, Yang L, Zhu W, et al. Clinical presentation, gene analysis and outcomes in young patients with early-treated combined methylmalonic acidemia and homocysteinemia (cblC type) in Shandong province, China. Brain Dev. 2016;38(5):491\u20137.","journal-title":"Brain Dev"},{"issue":"Suppl 3","key":"1485_CR18","doi-asserted-by":"crossref","first-page":"S435","DOI":"10.1007\/s10545-010-9217-0","volume":"33","author":"F Wang","year":"2010","unstructured":"Wang F, Han L, Yang Y, Gu X, Ye J, Qiu W, et al. Clinical, biochemical, and molecular analysis of combined methylmalonic acidemia and hyperhomocysteinemia (cblC type) in China. J Inherit Metab Dis. 2010;33(Suppl 3):S435\u201342.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"1485_CR19","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12881-018-0666-x","volume":"19","author":"S Hu","year":"2018","unstructured":"Hu S, Mei S, Liu N, Kong X. Molecular genetic characterization of cblC defects in 126 pedigrees and prenatal genetic diagnosis of pedigrees with combined methylmalonic aciduria and homocystinuria. BMC Med Genet. 2018;19(1):154.","journal-title":"BMC Med Genet"},{"issue":"10","key":"1485_CR20","doi-asserted-by":"crossref","first-page":"103713","DOI":"10.1016\/j.ejmg.2019.103713","volume":"62","author":"C Wang","year":"2019","unstructured":"Wang C, Li D, Cai F, Zhang X, Xu X, Liu X, et al. Mutation spectrum of MMACHC in Chinese pediatric patients with cobalamin C disease: a case series and literature review. Eur J Med Genet. 2019;62(10):103713.","journal-title":"Eur J Med Genet"},{"issue":"1","key":"1485_CR21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/humu.20258","volume":"27","author":"LC Worgan","year":"2006","unstructured":"Worgan LC, Niles K, Tirone JC, Hofmann A, Verner A, Sammak A, et al. Spectrum of mutations in Mut methylmalonic acidemia and identification of a common hispanic mutation and haplotype. Hum Mutat. 2006;27(1):31\u201343.","journal-title":"Hum Mutat"},{"issue":"10","key":"1485_CR22","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1002\/ajmg.a.37147","volume":"167","author":"L Han","year":"2015","unstructured":"Han L, Wu S, Ye J, Qiu W, Zhang H, Gao X, et al. Biochemical, molecular and outcome analysis of eight chinese asymptomatic individuals with methyl malonic acidemia detected through newborn screening. Am J Med Genet A. 2015;167(10):2300\u20135.","journal-title":"Am J Med Genet A"},{"issue":"1\u20132","key":"1485_CR23","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ymgme.2017.06.011","volume":"122","author":"M Almannai","year":"2017","unstructured":"Almannai M, Marom R, Divin K, Scaglia F, Sutton VR, Craigen WJ, et al. Milder clinical and biochemical phenotypes associated with the c. 482G> a (p. Arg161Gln) pathogenic variant in cobalamin C disease: implications for management and screening. Mol Genet Metab. 2017;122(1\u20132):60\u20136.","journal-title":"Mol Genet Metab"},{"issue":"10","key":"1485_CR24","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1097\/00001756-199907130-00009","volume":"10","author":"MR Fighera","year":"1999","unstructured":"Fighera MR, Queiroz CM, Stracke MP, Brauer MCN, Gonz\u00e1lez-Rodr\u00edguez LL, Frussa-Filho R, et al. Ascorbic acid and \u03b1-tocopherol attenuate methylmalonic acid-induced convulsions. Neuroreport. 1999;10(10):2039\u201343.","journal-title":"Neuroreport."},{"issue":"1\u20132","key":"1485_CR25","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/0006-8993(96)00117-5","volume":"721","author":"CF deMello","year":"1996","unstructured":"deMello CF, Begnini J, JimenezBernal RE, Rubin MA, deBastiani J, daCosta EM, et al. Intrastriatal methylmalonic acid administration induces rotational behavior and convulsions through glutamatergic mechanisms. Brain Res. 1996;721(1\u20132):120\u20135.","journal-title":"Brain Res"},{"issue":"18","key":"1485_CR26","doi-asserted-by":"crossref","first-page":"6920","DOI":"10.1523\/JNEUROSCI.20-18-06920.2000","volume":"20","author":"II Kruman","year":"2000","unstructured":"Kruman II, Culmsee C, Chan SL, Kruman Y, Guo Z, Penix L, et al. Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J Neurosci. 2000;20(18):6920\u20136.","journal-title":"J Neurosci"},{"issue":"1","key":"1485_CR27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10545-016-9991-4","volume":"40","author":"M Huemer","year":"2017","unstructured":"Huemer M, Diodato D, Schwahn B, Schiff M, Bandeira A, Benoist J-F, et al. Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency. J Inherit Metab Dis. 2017;40(1):21\u201348.","journal-title":"J Inherit Metab Dis"},{"issue":"11","key":"1485_CR28","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1073\/pnas.94.11.5923","volume":"94","author":"SA Lipton","year":"1997","unstructured":"Lipton SA, Kim WK, Choi YB, Kumar S, D'Emilia DM, Rayudu PV, et al. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc Natl Acad Sci U S A. 1997;94(11):5923\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"1485_CR29","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1089\/ars.2007.1750","volume":"9","author":"L Papatheodorou","year":"2007","unstructured":"Papatheodorou L, Weiss N. Vascular oxidant stress and inflammation in hyperhomocysteinemia. Antioxid Redox Signal. 2007;9(11):1941\u201358.","journal-title":"Antioxid Redox Signal"},{"issue":"3","key":"1485_CR30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1023\/A:1025555132675","volume":"18","author":"LMV De Almeida","year":"2003","unstructured":"De Almeida LMV, Funchal C, de Lima PP, Pessutto FDB, Loureiro SO, Vivian L, et al. Effect of propionic and methylmalonic acids on the in vitro phosphorylation of intermediate filaments from cerebral cortex of rats during development. Metab Brain Dis. 2003;18(3):207\u201319.","journal-title":"Metab Brain Dis"},{"issue":"1","key":"1485_CR31","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1212\/01.wnl.0000316391.40236.c3","volume":"71","author":"FG Debray","year":"2008","unstructured":"Debray FG, Boulanger Y, Khiat A, Decarie JC, Orquin J, Roy MS, et al. Reduced brain choline in homocystinuria due to remethylation defects. Neurology. 2008;71(1):44\u20139.","journal-title":"Neurology."},{"issue":"3","key":"1485_CR32","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ymgme.2013.07.018","volume":"110","author":"JD Weisfeld-Adams","year":"2013","unstructured":"Weisfeld-Adams JD, Bender HA, Miley-Akerstedt A, Frempong T, Schrager NL, Patel K, et al. Neurologic and neurodevelopmental phenotypes in young children with early-treated combined methylmalonic acidemia and homocystinuria, cobalamin C type. Mol Genet Metab. 2013;110(3):241\u20137.","journal-title":"Mol Genet Metab"},{"issue":"11","key":"1485_CR33","doi-asserted-by":"crossref","first-page":"e0165458","DOI":"10.1371\/journal.pone.0165458","volume":"11","author":"E Greibe","year":"2016","unstructured":"Greibe E, Nexo E. Forms and amounts of vitamin B12 in infant formula: a pilot study. PLoS One. 2016;11(11):e0165458.","journal-title":"PLoS One"},{"issue":"1","key":"1485_CR34","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ophtha.2013.08.034","volume":"121","author":"R Gizicki","year":"2014","unstructured":"Gizicki R, Robert M-C, Gomez-Lopez L, Orquin J, Decarie J-C, Mitchell GA, et al. Long-term visual outcome of Methylmalonic Aciduria and Homocystinuria, Cobalamin C Type. Ophthalmology. 2014;121(1):381\u20136.","journal-title":"Ophthalmology"},{"issue":"3","key":"1485_CR35","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ophtha.2015.10.041","volume":"123","author":"BP Brooks","year":"2016","unstructured":"Brooks BP, Thompson AH, Sloan JL, Manoli I, Carrillo-Carrasco N, Zein WM, et al. Ophthalmic manifestations and long-term visual outcomes in patients with Cobalamin C deficiency. Ophthalmology. 2016;123(3):571\u201382.","journal-title":"Ophthalmology."},{"issue":"5","key":"1485_CR36","first-page":"768","volume":"49","author":"XQ Liu","year":"2017","unstructured":"Liu XQ, Yan H, Qiu JX, Zhang CY, Qi JG, Zhang X, et al. Pulmonary arterial hypertension as leading manifestation of methylmalonic aciduria: clinical characteristics and gene testing in 15 cases. Beijing Da Xue Xue Bao. 2017;49(5):768.","journal-title":"Beijing Da Xue Xue Bao"},{"issue":"5","key":"1485_CR37","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00467-016-3399-0","volume":"32","author":"BB Beck","year":"2017","unstructured":"Beck BB, van Spronsen F, Diepstra A, Berger RMF, Komhoff M. Renal thrombotic microangiopathy in patients with cblC defect: review of an under-recognized entity. Pediatr Nephrol. 2017;32(5):733\u201341.","journal-title":"Pediatr Nephrol"},{"key":"1485_CR38","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s13023-014-0161-1","volume":"9","author":"M Huemer","year":"2014","unstructured":"Huemer M, Scholl-B\u00fcrgi S, Hadaya K, Kern I, Beer R, Seppi K, et al. Three new cases of late-onset cblC defect and review of the literature illustrating when to consider inborn errors of metabolism beyond infancy. Orphanet J Rare Dis. 2014;9:161.","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"1485_CR39","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ymgme.2006.04.001","volume":"88","author":"CF Morel","year":"2006","unstructured":"Morel CF, Lerner-Ellis JP, Rosenblatt DS. Combined methylmalonic aciduria and homocystinuria (cblC): phenotype\u2013genotype correlations and ethnic-specific observations. Mol Genet Metab. 2006;88(4):315\u201321.","journal-title":"Mol Genet Metab"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01485-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-020-01485-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01485-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T07:15:04Z","timestamp":1723360504000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-020-01485-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,3]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1485"],"URL":"https:\/\/doi.org\/10.1186\/s13023-020-01485-7","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,3]]},"assertion":[{"value":"16 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Hospital Institutional Ethics Committee and was conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from the parents of all patients for sample collection and publication of medical data.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"200"}}